FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server  |   User: [n/a]

1495581000168106: List of Medicines for Brand Consideration reference set (foundation metadata concept)


Status: current, Primitive. Date: 30-Sep 2020. Module: Third party reference set module

Descriptions:

Id Description Lang Type Status Case? Module Reference Sets
4462321000168116 List of Medicines for Brand Consideration reference set (foundation metadata concept) en Fully specified name Active Initial character case insensitive Third party reference set module
4462331000168118 List of Medicines for Brand Consideration reference set en Synonym Active Initial character case insensitive Third party reference set module Australian dialect reference set: Preferred
4462411000168119 List of Medicines for Brand Consideration (LMBC) reference set en Synonym Active Initial character case insensitive Third party reference set module Australian dialect reference set: Acceptable
4462641000168118 <p>Supports the identification of AMT Medicinal Product Unit of Use (MPUU) and Medicinal Product Pack (MPP) concepts associated with the List of Medicines for Brand Consideration (LMBC) under <i>The National Health (Pharmaceutical Benefits) Amendment (Active ingredient Prescribing) Regulations 2019 and The Veterans’ Affairs Pharmaceutical Benefits Schemes (Electronic Prescriptions and Active Ingredient Prescribing) Amendment Instrument 2019</i>.</p><p>This reference set can be used by prescribing software vendors to identify medications for brand consideration to meet Active Ingredient Prescribing requirements.</p><p><b>Target Client: </b>This reference set was developed by the National Clinical Terminology Service for the Australian Government Department of Health to support the Active Ingredient Prescribing initiative, and can be used by developers to assist with the requirements.</p> en Definition Active Case sensitive Third party reference set module

1535 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
List of Medicines for Brand Consideration reference set Is a Reference sets for Medications true Inferred relationship Some
List of Medicines for Brand Consideration reference set Is a Simple type reference set true Inferred relationship Some
List of Medicines for Brand Consideration reference set Developed by Australian Government Department of Health true Inferred relationship Some 1570063879

Members
Lactobacillus rhamnosus 15.55 billion CFU + Lactobacillus casei 9.45 billion CFU + Lactobacillus acidophilus 7.4 billion CFU + Lactobacillus plantarum 3.15 billion CFU + Lactobacillus fermentum 1.35 billion CFU + Bifidobacterium animalis 4.28 billion CFU + Bifidobacterium breve 1.35 billion CFU + Bifidobacterium bifidum 225 million CFU + Streptococcus thermophilus 2.25 billion CFU capsule
Lactobacillus rhamnosus 15.55 billion CFU + Lactobacillus casei 9.45 billion CFU + Lactobacillus acidophilus 7.4 billion CFU + Lactobacillus plantarum 3.15 billion CFU + Lactobacillus fermentum 1.35 billion CFU + Bifidobacterium animalis 4.28 billion CFU + Bifidobacterium breve 1.35 billion CFU + Bifidobacterium bifidum 225 million CFU + Streptococcus thermophilus 2.25 billion CFU capsule, 30
Lactobacillus rhamnosus 15.55 billion CFU + Lactobacillus casei 9.45 billion CFU + Lactobacillus acidophilus 7.4 billion CFU + Lactobacillus plantarum 3.15 billion CFU + Lactobacillus fermentum 1.35 billion CFU + Bifidobacterium animalis 4.28 billion CFU + Bifidobacterium breve 1.35 billion CFU + Bifidobacterium bifidum 225 million CFU + Streptococcus thermophilus 2.25 billion CFU capsule, 60
Bifidobacterium bifidum 1 billion CFU + Lactobacillus acidophilus 1 billion CFU capsule
Bifidobacterium bifidum 1 billion CFU + Lactobacillus acidophilus 1 billion CFU capsule, 20
Bifidobacterium bifidum 31.25 million CFU + Bifidobacterium lactis 12.47 billion CFU + Lactobacillus acidophilus 6.25 billion CFU + Lactobacillus paracasei 6.25 billion CFU capsule
Bifidobacterium bifidum 31.25 million CFU + Bifidobacterium lactis 12.47 billion CFU + Lactobacillus acidophilus 6.25 billion CFU + Lactobacillus paracasei 6.25 billion CFU capsule, 150
Bifidobacterium bifidum 31.25 million CFU + Bifidobacterium lactis 12.47 billion CFU + Lactobacillus acidophilus 6.25 billion CFU + Lactobacillus paracasei 6.25 billion CFU capsule, 30
Bifidobacterium bifidum 31.25 million CFU + Bifidobacterium lactis 12.47 billion CFU + Lactobacillus acidophilus 6.25 billion CFU + Lactobacillus paracasei 6.25 billion CFU capsule, 90
Bifidobacterium bifidum 500 million CFU + Bifidobacterium lactis 2 billion CFU + Lactobacillus acidophilus 10 billion CFU + Lactobacillus paracasei 12.5 billion CFU capsule
Bifidobacterium bifidum 500 million CFU + Bifidobacterium lactis 2 billion CFU + Lactobacillus acidophilus 10 billion CFU + Lactobacillus paracasei 12.5 billion CFU capsule, 30
amphotericin B (as lipid complex) 100 mg/20 mL injection, 20 mL vial
amphotericin B (as lipid complex) 100 mg/20 mL injection, 10 x 20 mL vials
amphotericin B (as lipid complex) 100 mg/20 mL injection, vial
amphotericin B 50 mg injection, 1 vial
amphotericin B 50 mg injection, vial
azelastine 125 microgram/actuation + fluticasone propionate 50 microgram/actuation nasal spray, 120 actuations
azelastine 125 microgram/actuation + fluticasone propionate 50 microgram/actuation nasal spray, actuation
beclometasone dipropionate 100 microgram/actuation + formoterol (eformoterol) fumarate dihydrate 6 microgram/actuation + glycopyrronium 10 microgram/actuation inhalation, 120 actuations
beclometasone dipropionate 100 microgram/actuation + formoterol (eformoterol) fumarate dihydrate 6 microgram/actuation + glycopyrronium 10 microgram/actuation inhalation, actuation
beclometasone dipropionate 100 microgram/actuation + formoterol (eformoterol) fumarate dihydrate 6 microgram/actuation inhalation, 120 actuations
beclometasone dipropionate 100 microgram/actuation + formoterol (eformoterol) fumarate dihydrate 6 microgram/actuation inhalation, actuation
beclometasone dipropionate 100 microgram/actuation inhalation, 100 actuations
beclometasone dipropionate 100 microgram/actuation inhalation, 200 actuations
beclometasone dipropionate 100 microgram/actuation inhalation, actuation
beclometasone dipropionate 50 microgram/actuation inhalation, 100 actuations
beclometasone dipropionate 50 microgram/actuation inhalation, 200 actuations
beclometasone dipropionate 50 microgram/actuation inhalation, actuation
beclometasone dipropionate 50 microgram/actuation nasal spray, 100 actuations
beclometasone dipropionate 50 microgram/actuation nasal spray, 2 x 200 actuations
beclometasone dipropionate 50 microgram/actuation nasal spray, 200 actuations
beclometasone dipropionate 50 microgram/actuation nasal spray, actuation
levodopa 50 mg + benserazide 12.5 mg capsule
levodopa 50 mg + benserazide 12.5 mg capsule, 100
levodopa 50 mg + benserazide 12.5 mg dispersible tablet
levodopa 50 mg + benserazide 12.5 mg dispersible tablet, 100
levodopa 100 mg + benserazide 25 mg capsule
levodopa 100 mg + benserazide 25 mg capsule, 100
levodopa 100 mg + benserazide 25 mg dispersible tablet
levodopa 100 mg + benserazide 25 mg dispersible tablet, 100
levodopa 100 mg + benserazide 25 mg modified release capsule
levodopa 100 mg + benserazide 25 mg modified release capsule, 100
levodopa 100 mg + benserazide 25 mg tablet
levodopa 100 mg + benserazide 25 mg tablet, 100
levodopa 200 mg + benserazide 50 mg capsule
levodopa 200 mg + benserazide 50 mg capsule, 100
levodopa 200 mg + benserazide 50 mg tablet
levodopa 200 mg + benserazide 50 mg tablet, 100
betamethasone (as valerate) 0.1% cream
betamethasone (as valerate) 0.1% cream, 100 g
betamethasone (as valerate) 0.1% cream, 2 g
betamethasone (as valerate) 0.1% cream, 30 g
betamethasone (as valerate) 0.02% cream
betamethasone (as valerate) 0.02% cream, 100 g
betamethasone (as valerate) 0.02% cream, 2 g
betamethasone (as valerate) 0.02% cream, 5 g
betamethasone (as valerate) 0.05% cream
betamethasone (as valerate) 0.05% cream, 15 g
betamethasone (as valerate) 0.05% cream, 2 g
betamethasone (as valerate) 0.05% cream, 30 g
leuprorelin acetate 22.5 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe] (&) bicalutamide 50 mg tablet [28], 1 pack
leuprorelin acetate 7.5 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe] (&) bicalutamide 50 mg tablet [28], 1 pack
leuprorelin acetate 22.5 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe] (&) bicalutamide 50 mg tablet [84], 1 pack
bimatoprost 0.01% eye drops
bimatoprost 0.01% eye drops, 3 mL
bimatoprost 0.03% + timolol 0.5% eye drops, unit dose
bimatoprost 0.03% + timolol 0.5% eye drops, 10 x 0.4 mL unit doses
bimatoprost 0.03% + timolol 0.5% eye drops, 30 x 0.4 mL unit doses
bimatoprost 0.03% + timolol 0.5% eye drops, 5 x 0.4 mL unit doses
bimatoprost 0.03% eye drops, unit dose
bimatoprost 0.03% eye drops, 30 x 0.4 mL unit doses
bimatoprost 0.03% eye drops, 5 x 0.4 mL unit doses
bimatoprost 0.03% + timolol 0.5% eye drops
bimatoprost 0.03% + timolol 0.5% eye drops, 3 mL
bimatoprost 0.03% eye drops
bimatoprost 0.03% eye drops, 3 mL
bimatoprost 0.03% eye drops, 3 x 3 mL
botulinum toxin type A 100 units injection, 1 vial
botulinum toxin type A 100 units injection, vial
botulinum toxin type A 200 units injection, 1 vial
botulinum toxin type A 200 mouse LD50 units injection, 200 mouse LD50 units vial (medicinal product unit of use)
botulinum toxin type A 50 units injection, 1 vial
botulinum toxin type A 50 units injection, vial
brimonidine 0.33% gel
brimonidine 0.33% gel, 10 g
brimonidine 0.33% gel, 30 g
brimonidine tartrate 0.15% eye drops
brimonidine tartrate 0.15% eye drops, 5 mL
brinzolamide 1% + brimonidine tartrate 0.2% eye drops
brinzolamide 1% + brimonidine tartrate 0.2% eye drops, 5 mL
brimonidine tartrate 0.2% + timolol 0.5% eye drops
brimonidine tartrate 0.2% + timolol 0.5% eye drops, 5 mL
brimonidine tartrate 0.2% eye drops
brimonidine tartrate 0.2% eye drops, 5 mL
brinzolamide 1% + timolol 0.5% eye drops
brinzolamide 1% + timolol 0.5% eye drops, 5 mL
brinzolamide 1% eye drops
brinzolamide 1% eye drops, 10 mL
brinzolamide 1% eye drops, 5 mL
buprenorphine 1.4 mg + naloxone 360 microgram sublingual tablet
buprenorphine 1.4 mg + naloxone 360 microgram sublingual tablet, 28

Page 1 of 16 Next End


Reference Sets

Reference set descriptor

Back to Start